Basics Sight Sciences, Inc. Common Stock IPO Date: July 12, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $425.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.60% Avg Daily Range (30 D): $0.24 | 3.45% Avg Daily Range (90 D): $0.15 | 2.96% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .14M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 122 Avg Inst. Trade: $2.34M Avg Inst. Trade (30 D): $2.2M Avg Inst. Trade (90 D): $2.2M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.59M Avg Closing Trade (30 D): $2.2M Avg Closing Trade (90 D): $2.2M Avg Closing Volume: 266.49K     News Sep 9, 2025 @ 3:39 PM UnitedHealthcare Adds Sight Sciences OMNI System T... Source: Vandana Singh Jul 30, 2025 @ 11:00 AM Sight Sciences Announces the Results of a Cost-Uti... Source: Nathan Lighthizer Et Al. Jul 29, 2025 @ 11:00 AM Sight Sciences Announces the Publication of the 24... Source: Sight Sciences, Inc. Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.9 $-.16 $-.23 Diluted EPS $-.9 $-.16 $-.23 Revenue $ 76.05M $ 19.91M $ 19.56M Gross Profit $ 65.44M $ 17.2M $ 16.59M Net Income / Loss $ -46.11M $ -8.17M $ -11.94M Operating Income / Loss $ -45.36M $ -7.91M $ -11.67M Cost of Revenue $ 10.61M $ 2.71M $ 2.98M Net Cash Flow $ -25.93M $ -8.86M $ -18.86M PE Ratio